Lupus nephritis (LN) is a form of glomerulonephritis that constitutes one of the most severe
organ manifestations of the autoimmune disease systemic lupus erythematosus (SLE). Most …

Systemic Lupus Erythematosus (SLE) is associated with increased risk for accelerated
atherosclerosis and cardiovascular (CV) events including coronary heart disease …

Objective To develop recommendations for cardiovascular risk (CVR) management in gout,
vasculitis, systemic sclerosis (SSc), myositis, mixed connective tissue disease (MCTD) …

Our objective was to update the EULAR recommendations for the management of systemic
lupus erythematosus (SLE), based on emerging new evidence. We performed a systematic …

Dysregulation of lymphocyte function, accumulation of autoantibodies and defective
clearance of circulating immune complexes and apoptotic cells are hallmarks of systemic …

Systemic lupus erythematosus (SLE) often features extensive cardiovascular (CV)
comorbidity and patients with SLE are at significantly increased risk of CV event occurrence …

Objective. Systemic lupus erythematosus (SLE) is associated with an increased risk of
cardiovascular disease (CVD). Thromboprophylaxis with low-dose aspirin (ASA) and …

Evidence now indicates that inflammation contributes considerably to the initiation and
progression of atherosclerosis and active inflammatory processes may trigger plaque …

Objectives Systemic lupus erythematosus (SLE) is associated with an increased
cardiovascular risk. Several traditional and disease-specific risk factors have been shown to …

Vascular disease is a major cause of morbidity and mortality in patients with systemic
autoimmune diseases, particularly systemic lupus erythematosus (SLE). Although comorbid …